top of page

日本人

★★

イメグリミンが効きやすい患者背景は?

Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post-hoc analysis of two randomized, placebo-controlled trials. J Diabetes Investig. 2023 Sep;14(9):1101-1109. doi: 10.1111/jdi.14035. Epub 2023 Jun 1. PMID: 37264517; PMCID: PMC10445191.

23/6/1

J Diabetes Investig

介入試験

イメグリミン第2,3相試験のプール解析。年齢、肥満、DM病歴、CKD、過去の薬剤、高血圧、脂質異常症、肝線維化、すべての層別解析でA1c低下効果あり。

bottom of page